Purpose of Study It is the second decade of controversy regarding the cardiovascular (CV) effects of cycloxygenase-2 (COX-2) inhibitors. COX-2 inhibitors possess anti-inflammatory and analgesic effects comparable with conventional non-steroidal anti-inflammatory drugs, but produce fewer gastrointestinal adverse effects. Here we demonstrate that only selective COX-2 inhibitors cause disruption of the delicate balance between cholesterol efflux and influx that leads to lipid overload and macrophage foam cell formation (FCF). Methods Used THP-1 human macrophages were incubated with: celecoxib (10 mM, 25 mM); rofecoxib (10 mM, 25 mM); naproxen (10 mM, 25 mM); acetaminophen (0.5 mM, 1 mM)±oxidized low density lipoprotein (oxLDL, 25 mg/ml, 48 h) or 5 mg/ml (Dil)-oxLDL. FCF (% oil red O stained cells) and oxLDL accumulation were determined (fluorescent intensity). Scavenger receptors: CD36, LOX-1, SR-A1 and CXCL16 and cholesterol efflux proteins: ATP-binding cassette transporter (ABC) A1 and ABCG1 were detected in macrophages by QRT-PCR and immunocytochemistry. Summary of Results Celecoxib decreased ABCA1 and ABCG1 message in a concentration dependent manner: 68.2 ±13.36% for ABCA1 and 65.7±13.36% for ABCG1 (control set at 100%, n=6, P<0.01). Neither naproxen nor acetaminophen significantly affected expression of cholesterol efflux proteins. Both specific and nonspecific COX-2 inhibitors had a significant impact on expression of scavenger receptors CD36, LOX-1 and SR-A1-nearly double control (n=6, P<0.05). However, only specific COX-2 inhibitors significantly increased FCF in THP-1 differentiated macrophages (62.2±5.2% for celecoxib and 56.3±3.4% for rofecoxib vs. 33.5±5.1% for untreated cells, P<0.05). Conclusions Here we report that only specific COX-2 inhibitors might contribute to atherogenesis by promoting lipid overload and lipoprotein accumulation. This may explain, in part, the increased CV risk in patients taking COX-2 inhibitors for extended periods. Despite increased scavenger receptor expression, naproxen and acetaminophen do not impact lipid content, perhaps because efflux pathways remain intact. Purpose of Study Advanced glycation end products (AGE), proteins formed by nonenzymatic glycation, are prevalent in patients with diabetes mellitus (DM) and contribute to the development of atherosclerosis. We have demonstrated that plasma from patients with type 1 DM (T1DM) decreases expression of cholesterol efflux proteins in cultured THP-1 macrophages compared to healthy control (HC) plasma. Here we explore a mechanism that restores cholesterol efflux in T1DM plasma through blockade of the receptor for AGE (RAGE). Methods Used Carboxy-methyl-lysine-modified proteins (CML-MP), the most prevalent AGE in vivo, were measured in the plasma of 20 pediatric T1DM patients and 20 sex and age-matched HC by ELISA. THP-1 macrophages (10 6 /ml) were incubated for 18 h in RPMI media in the presence of 10% plasma from each enrolled patient in triplicate±anti-RAGE antibody. Cholesterol efflux proteins: ATP binding cassette transporter (ABC)A1 and 27-hydroxylase were quantified by real-time RT-PCR using specific primers for each gene.
Purpose of Study Advanced glycation end products (AGE), proteins formed by nonenzymatic glycation, are prevalent in patients with diabetes mellitus (DM) and contribute to the development of atherosclerosis. We have demonstrated that plasma from patients with type 1 DM (T1DM) decreases expression of cholesterol efflux proteins in cultured THP-1 macrophages compared to healthy control (HC) plasma. Here we explore a mechanism that restores cholesterol efflux in T1DM plasma through blockade of the receptor for AGE (RAGE). Methods Used Carboxy-methyl-lysine-modified proteins (CML-MP), the most prevalent AGE in vivo, were measured in the plasma of 20 pediatric T1DM patients and 20 sex and age-matched HC by ELISA. THP-1 macrophages (10 6 /ml) were incubated for 18 h in RPMI media in the presence of 10% plasma from each enrolled patient in triplicate±anti-RAGE antibody. Cholesterol efflux proteins: ATP binding cassette transporter (ABC)A1 and 27-hydroxylase were quantified by real-time RT-PCR using specific primers for each gene.
Summary of Results
The level of CML-MP was significantly elevated in T1DM plasma (1.65±1.3 ng/ml) versus HC plasma (1.05±0.4 ng/ml) (P<0.05, n=20). ABCA1 expression was significantly lower in macrophages exposed to T1DM plasma (1.108±0.8 U) versus HC plasma (1.624 ±0.6) (P<0.05, n=20). Exposure of THP-1 macrophages to T1DM plasma downregulated 27-hydroxylase mRNA to 1.94±0.9 U in T1DM versus 3.4±2.9 U in HC (P<0.01, n=20). Inactivation of RAGE before exposure to T1DM plasma increased ABCA1 expression by 20%. However, we observed no effect on the level of 27-hydroxylase. Conclusions We demonstrate that elevated AGE in plasma of T1DM patients inhibits cholesterol efflux and suppresses intracellular cholesterol processing via 27-hydroxylase and ABCA1 in naïve macrophages. RAGE inactivation restores mRNA level of the ABCA1 transporter, but not the 27-hydroxylase enzyme. These findings impart new targets for prevention of cardiovascular disease in DM and suggest that factors other than AGE may impact cholesterol transport.
Purpose of Study Age-associated chronic diseases are associated with a pro-inflammatory state. It has been challenging to determine cause and effect -do age-associated pathologies increase inflammation or does inflammation induce age-associated pathologies or both? We previously showed that disease-related regenerative asynchrony in repairing lung is the cause of chronic inflammation and fibrosis. Thus, we hypothesized that the aged lung is itself asynchronously regenerating leading to a pro-inflammatory pulmonary milieu. Methods Used Tracheas and intra-cardiac blood were harvested from C57BL6 mice in two age groups of both genders. Young mice were between 8 and 20 weeks of age. Aged mice were between 23 and 33 months of age. Tracheal epithelial progenitor cells were isolated and cultured for 6 days with continuous exposure to BrdU. Cellular regeneration was analyzed by flow cytometry for 7-AAD DNA staining in BrdU + cells. Concentrations of an initial screening set of cytokines in plasma and cell culture supernatants from days 2 and 6 of culture were measured using magnetic bead-based assays. Summary of Results Fewer airway epithelial progenitors underwent mitosis from the aged than the young mice (16.9±10.4% vs. 62.2±9.4% of the cultured cells at 6 days). The tracheal epithelial progenitors from aged mice were asynchronously distributed along the cell cycle (G 1 , S, G 2 /M: 44, 25, and 31%) compared to those from young mice (62, 14, and 24%) . Plasma concentrations of IL-1β, IL-6, TNFα and TGFβ were not significantly different between age groups. Concentrations of TGFβ were significantly different between age groups in supernatant from day 2 (aged=112.43±16.31 pg/mL, young=171.23 ±13.70 pg/mL; p<0.05) but not from day 6 of culture (aged=159.60±29.83 pg/mL, young=214.15±.94 pg/mL; p=NS). Concentrations of IL-1β were not significantly different between age groups in supernatant from day 2 of culture (aged=2.01±0.23 pg/mL, young=2.10±0.24 pg/ mL; p=NS) but remained higher in aged compared to young progenitors on day 6 (aged: 2.17±0.31 pg/mL, young: 1.26±0.10 pg/mL; p<0.05). Conclusions Our data support the concept that aging induces progenitor cell mitotic asynchrony. It is possible that this epithelial mitotic asynchrony contributes to the pro-inflammatory state associated with aging, as seen in other chronic inflammatory states.
QUANTITATIVE ANALYSIS OF DESMOPRESSIN (DDAVP) RESPONSE IN ADULT PATIENTS WITH TYPE 1 VON WILLEBRAND DISEASE
Purpose of Study Patients with Type I vWD have reduced amounts of Willebrand Factor (vWF) in their blood.
Desmopressin (DDAVP) has been used to raise the serum levels of vWF in these patients. However, not all patients with Type 1 vWD are known to respond to DDAVP therapy. We sought to compare the levels Factor VIII, vWF antigen, ristocetin and fibrinogen at different time points to determine the single most useful time point for ascertaining the patient as a responder. Methods Used Levels of Factor VIII, vWF antigen, ristocetin and fibrinogen has been conventionally measured at multiple time points after a DDAVP challenge. We conducted a retrospective analysis on 89 patients who received the DDAVP challenge test and compared their factor levels at 0, 30, 60, 90 and 120 minutes. Summary of Results Levels of Factor VIII, vWF antigen ristocetin and fibrinogen were significantly elevated (p<0.001) at 30, 60, 90 and 120 minute time points when compared to their baseline values. A downtrend was noted for Factor VII, vWF antigen and ristocetin levels at the 90 minute time point but fibrinogen levels did not significantly change compared to the baseline level.
Conclusions In this study we show that measurement of factor levels at any one time point, preferably at 60 minutes is sufficient to diagnose a patient as a responder after a DDAVP challenge test. Curtailing the number of time points of measurement will result in significant savings in cost and time to patients and their providers.
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UNABLE TO BE PUBLISHED 10.1136/jim-2016-000080.6 Unable to be published. Purpose of Study More than 100,000 pelvic surgeries to remove ovarian masses (BOM) are performed yearly in the USA only 8% of those remove ovarian cancer. Circulating microRNA are biomarkers for disease detection. Purpose of study: 1. To analyze patterns of microRNAs in women with BOM vs. OvCa 2. Discover pathway involved malignant transformation. Methods Used Plasma from 32 women OvCa, 24 controls 32 (BOM) was analyzed using ABI Taqman OpenArray MicroRNA pools A and B to measure the expression of 754 known miRNAs .Real-time PCR was performed on the Taqman Open Array MicroRNA arrays using the Applied Biosystem Open Array Real-Time PCR system. Data were processed using the OpenArray Real-Time qPCR Analysis software and exported for analysis using the Applied Biosystems DataAssist Software Data analysis was done with the R programming language. A cutoff for Ct values at 30 was used. MiRNAs with Ct values higher than 30 were considered not detected. Data was normalized using a mean-centering restricted (MCR), a modification of the traditional delta Ct method and uses miRNAs which are expressed in all samples for data normalization. Statistical analysis was performed via custom scripts based on the R/ Bioconductor package LIMMA (Linear Models for Microarray). Summary of Results BOM had higher expression (2-14 fold higher) of . OvCa over-expressed of miRs −1274a, −720 and −625-3p ( p<0.0007). Reactome pathway analysis detected involvement of miRs into pathways of activation of BAD, PI3/AKT signaling in CD28 and activation of BH3 in BOM these pathways were not detected in OvCa ( p<0.000596). Conclusions BOM patients have immune recognition and pro-apoptotic protective circulating microRNAs. It is unknown whether miRs originate in ovary or another tissue. Recent work shows that BH3 mimetics are very effective in inducing cancer cell death. Purpose of Study Asthma is typically treated acutely with β2-agonists and systemic steroids. Adjunctive therapies such as magnesium sulfate (MgSO 4 ) have proven useful with early addition potentially improving clinical outcomes in asthma (reduced hospital admission rates, length of stay and intubation rates). Exact administration time and impact on outcomes in children are not fully understood. We sought to identify the impact of timing of initiating MgSO 4 therapy in innercity children admitted for status asthmaticus. Methods Used We performed a retrospective chart review of children (age 2-21 yrs) admitted to a children's hospital over a 12 month period with asthma exacerbation and administered MgSO 4 . Data collected included ethnicity, gender, medications, timing of interventions, length of stay, BMI percentile, comorbidities and NAEPP asthma severity. Statistical analysis performed with SPSS 22. Summary of Results 150 innercity children were admitted for asthma exacerbation and received MgSO 4 during the study period. 85% were African American, 36% female, 39% had moderate/severe asthma and mean time to initial MgSO 4 was 3.8 hours from triage. Those receiving initial MgSO 4 after 4 hours were more likely to receive multiple doses of MgSO Conclusions Delay in administration of MgSO 4 in children hospitalized for status asthmaticus may be associated with poor outcomes including multiple doses of MgSO 4 which in turn is associated with longer length of stay and increased charges. Obesity and asthma severity are important factors associated with these outcomes. A prospective analysis in a larger cohort is recommended to further evaluate these findings.
INTEGRATED PATHWAY ANALYSIS OF MICRORNA EXPRESSION IN PLASMA OF OVARIAN CANCER (OVCA) PATIENTS SHOWS LACK OF BH3 PROTEIN DEPENDENT SIGNALING
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IMPACT OF LATE USE MAGNESIUM SULFATE IN INNER CITY CHILDREN HOSPITALIZED FOR ASTHMA EXACERBATION
Purpose of Study Limited models exist to investigate the airway epithelium's role in repair, regeneration, and pathology of chronic obstructive lung diseases. We introduce a human asthmatic airway epithelial xenograft system integrating a proliferating and differentiating airway epithelium with an actively remodeling rodent mesenchyme in an immunocompromised murine host. We hypothesized that epithelial regeneration in asthma induces underlying matrix fibrosis. Methods Used Human airway epithelial cells from asthmatic and non-asthmatic donors (n=5 per group) were seeded into decellularized rat tracheas. Tracheas were ligated to a sterile tubing cassette and implanted subcutaneously in the flanks of athymic nude mice. Grafts were harvested at 2, 4, or 6 weeks for analysis of tissue histology, fibrillar collagen deposition, and TGFβ1 activation. Non-transplantable human lungs from asthmatic and nonasthmatic donor FFPE sections were analyzed using similar methods. Summary of Results Grafted epithelial cells generated a differentiated epithelium with basal, ciliated, and mucus cells. By 4 weeks post-engraftment, asthmatic-derived epithelia showed decreased numbers of ciliated cells and E-cadherin expression compared to non-asthmatic controls, similar to human lung biopsy tissue. While there was no evidence of matrix remodeling in acellular xenografts, grafts seeded with asthmatic-derived epithelial cells had 3 times as much fibrillar collagen at 6 weeks postengraftment as non-asthmatic epithelial seeded grafts. This was accompanied by a >2-fold induction of matrix TGFβ1 [with evidence of pSMAD3 activity] in asthmatic grafts at 4 weeks ( positive pixels/total field pixels=0.12±0.001 vs. 0.05±0.001; p=0.003) and 6 weeks (0.09±0.02 vs. 0.04 ±0.01; p=0.044) post-engraftment. Conclusions We show in this model that asthmatic epithelium alone is sufficient to drive aberrant mesenchymal remodeling, specifically with fibrillar collagen deposition in asthmatic-derived xenografts.These xenografts are a major advance over current animal models of asthma in that they permit direct assessment of the epithelial-mesenchymal trophic unit. Purpose of Study Chronic kidney disease (CKD) is a known risk factor for cardiovascular disease (CVD). Patients with CKD have a high prevalence of atherosclerosis. However, CVD risk associated with CKD is not entirely explained by standard lipid profile or liver handling of cholesterol, as evidenced by the resistance to statin benefits seen in later stages of CKD. This study aims to detect changes in expression of cholesterol transport proteins in the setting of CKD and to determine if such changes adversely affect lipid handling by macrophages leading to cholesterol overload and atheromatous foam cell formation. Methods Used THP-1 human macrophages (10 6 /ml) were incubated for 18 h-24 h with plasma obtained from 10 CKD patients (7 male, 3 female) or 10 healthy control subjects (4 male, 6 female). CKD patients were not on dialysis and had not received renal transplant. Following incubation, mRNA was isolated and reverse transcribed. The resulting cDNA was subjected to quantitative real-time PCR using specific primers for ATP binding cassette transporter (ABC)A1 (cholesterol efflux protein) and CD36, (a scavenger receptor with the capacity to endocytose oxidized LDL). Summary of Results PCR analysis showed that ABCA1 mRNA was reduced by 23±5% ( p<0.0001) while CD36 mRNA was decreased by 36±7% ( p<0.0001) in macrophages exposed to CKD plasma as compared to healthy control. Conclusions These findings suggest a different mechanism of lipid dysregulation associated with CKD that may explain the pathogenesis of elevated CVD risk in CKD and lack of response to statins. This mechanism, through pro-atherogenic suppression of ABCA1, differs from our finding in autoimmune rheumatic diseases where, in addition to lowering of ABCA1, augmentation of CD36 was also observed. In CKD, a paradoxical decrease in CD36 could compromise macrophage clearance of lipids, increasing vulnerability to lipoprotein thrombi in kidney. Further lowering of monocyte CD36 with statins would be of little benefit if CD36 is already low in CKD. Defining changes in lipid handling in CKD could lead to novel, targeted CVD treatment approaches in the CKD population. Purpose of Study Methotrexate (MTX) is an antirheumatic drug with atheroprotective properties mediated through adenosine release and activation of the adenosine A 2A receptor (A 2A R). A 2A R ligation increases reverse cholesterol transport via upregulation of cholesterol efflux proteins ATP-binding cassette transporter (ABC)A1 and ABCG1, liver X receptor (LXR) and cholesterol 27-hydroxylase. MTX is non-specific and associated with adverse effects on liver and kidney. Therefore, this study examines the anti-atherogenic efficacy of a specific A 2A R agonist, UK-432,097, a drug with an established safety profile in humans. Methods Used THP-1 human macrophages were incubated in the following conditions: (1) RPMI media (untreated control); (2) dimethyl sulfoxide vehicle control; (3) UK-432,097 (100 nM); (4) ZM-241385 (1 mM) (A 2A R antagonist)+UK-432,097 (100 nM). Gene expression analysis was performed using QRT-PCR for cholesterol efflux genes, normalized to the housekeeping gene GAPDH. Western blotting was performed using specific antibodies. All data were analyzed by one-way ANOVA with P values <0.05 considered significant. Purpose of Study Studies have linked the use of antisecretory agents to nosocomial complications including Clostridium difficile-induced pseudomembranous colitis and hospital acquired pneumonia. Although there are comprehensive evidence-based guidelines for the initiation of stress ulcer prophylaxis, there are no universally accepted approaches. This has caused nationwide disorganization in current practice, which has led to their overuse. While many studies have shown the pervasiveness of stress ulcer prophylaxis overuse in the hospital setting, none have demonstrated its effect on the community through the improper discharge of patients on these medications. Methods Used A retrospective review of patient data at a major teaching hospital in New York City was performed. During a 2 month study period, adult non-intensive care patients were randomly selected to determine the incidence of inappropriate initiation of stress ulcer prophylaxis on admission, as compared to the incidence of appropriate use. A follow-up assessment was then completed to determine the incidence of patients that were inappropriately discharged on these medications. Summary of Results A total of 100 randomly selected patients throughout the inpatient medicine service were analyzed. The results showed a high rate of inappropriate initiation and discharge of patients on anti-secretory agents. The study showed a 50% (n=50) incidence of overall stress ulcer prophylaxis use. Of the patients on stress ulcer prophylaxis, a 76% (n=38) incidence of inappropriate use was found. Of the patients inappropriately on stress ulcer prophylaxis, there was a 53% (n=19) incidence of inappropriate discharge home on these medications. Conclusions This study highlights the continued inappropriate initiation and discharge of patients on anti-secretory agents, despite mounting evidence and advisories against this practice. The use of an electronic medical record could provide an additional resource to improve quality of care. Electronic prescriptions allow for prompts that ask for a clinical indication during the prescription process. The advent of this technology may yield even more promising improvements in clinical practice, and its implementation is the current focus of a continuing study. , HbA1c 10.2±0.6%), compared with n=12 type 2 diabetes subjects (T2DM, BMI 25.7±0.3 kg/ m2, HbA1c 9.7±0.6%) and n=12 age and BMI matched non-diabetic (ND) subjects and n=16 with type 1 diabetes (T1DM, HbA1c 9.1±0.3%). Therapeutic regimens were intensified for two weeks to correct glucose toxicity in all groups. Lean body mass was determined for all subjects from percentage of total body fat as assessed by DXA. Summary of Results Peripheral insulin sensitivity (Rd, mg/ kg lean body weight/min), was markedly impaired in T2DM (2.3±0.6; p<0.01) compared to LD (9.2±1.6) and FCPD (5.8±0.7). Rd did not differ between T1DM (5.8±0.7), LD and FCPD groups (figure 1). Purpose of Study ATL is a peripheral T-cell neoplasm (PTCL) associated with human T-cell lymphotropic virus-1 (HTLV-1) infection. Currently there is no established therapy for relapsed/refractory disease. Initial in-vitro studies of HDAC inhibitors showed selective apoptosis of HTLV-1 infected T cell lines. In phase II trial for relapsed/ refractory PTCL, 2 patients had EBV and 1 patient had HBV reactivation. It was unclear if this was from HDAC induced immunosuppression or direct promotion of viral replication or underlying disease process. All HDAC inhibitors trials in last 6 years excluded ATL patients although they are approved for this disease. We here describe our experience of 3 patients with relapsed/refractory ATL treated with HDAC inhibitor romidepsin. Methods Used Chart review of patients with relapsed/ refractory ATL treated with romidepsin at King's County Hospital. Summary of Results Case 1: 43 year old male with acute ATL who progressed on EPOCH after 4 cycles. Romidepsin was started at 14 mg/m2 IV Day 1, 8, 15 Q28 days. He tolerated cycle 1 well but continued to have progressive disease. Patient died 40 days after initiation of therapy from infection. Case 2: 37 year old male with acute ATL who had disease progression on EPOCH×2 cycles. He was started on romidepsin 10 mg/m 2 IV (dose reduced due to T. bili 3.5 gm/ dl). After first dose, his platelets dropped to to 20 k/mm 3 necessitating treatment delay and dose reduction to 6 mg/ m2. He had temporary response as evidenced by reduction in WBC count from 103 kmm 3 to 5 k/mm 3 and improvement in liver function. He only received 1 cycle and died on Day 50 from disease progression. Case 3: 47 year old male with ATL lymphoma intially treated with CHOP×6 cycles and relapsed after 1 year with peripheral lymphocytosis to 57 k/mm 3 and diffuse lymphadenopathy. He received ICE×2 cycles with progressive disease. He was started on romidepsin 14 mg/m 2 . He received 1 dose and had Grade IV anemia/thrombocytopenia. He developed urosepsis and expired on Day 20. Conclusions In our small experience of romidepsin in relapsed/refractory ATL, patients appear to have modest response rates and higher rate of cytopenias when compared to other PTCL subtypes in clinical trials. Given the concerns for viral reactivation and lack of data for use of romidepsin in ATL, it should be used cautiously. Purpose of Study This study aimed at characterizing the secretome of HMEEC-1 and to evaluate its regulation in response to NTHi lysates and better understand the pathogenesis of Otitis Media (OM). Methods Used HMEEC-1 were labeled with heavy isotopes of arginine and lysine to obtain a spike-in standard that was mixed with the conditions of interest (control or treated 24 hrs, secretions recovered 24 hrs or 48 hrs) and separated by SDS-PAGE. Peptides generated by in-gel digestion were analyzed by LC-MS/MS. Middle ear effusions (MEEs) from patients having chronic OM were analyzed to validate the results obtained with HMEEC. Summary of Results 767 proteins were detected by MS in HMEEC secretions. The more abundant proteins detected were components of the extracellular matrix, proteins implicated in the innate immune response, and surprisingly proteins implicated in the processing and packaging of RNA. These proteins were heterogenous nuclear ribonucleoproteins A2/B1 (hnRNPA2B1) and K (hnRNPK) enriched at the 24 hrs time point (1.99 and 1.78 fold change respectively) and Q at 48 hrs (hnRNPQ, fold change 4.76) in response to NTHi lysates. We then hypothesized that these proteins were implicated in the packaging of miRNAs in exosomes in response to NTHi lysates. An exosome marker assay showed the presence of exosomes in both the cell secretions and MEEs. A western blot analysis of MEE exosome proteins showed the presence of hnRNPs as in cell secretions. Finally, a Nanostring chip assay demonstrated the presence of 8 miRNA in MEEs, mostly reported to be produced by epithelial cells and neutrophils. Conclusions We characterized the secretome of HMEEC in response to NTHi lysates treatment that show a potential implication of exosomes in the pathogenesis of OM. We demonstrated the presence of exosomes in HMEEC secretions and MEEs, transporting miRNAs packaged by hnRNP proteins. Purpose of Study Homocysteine is an independent risk factor of ischemic stroke by promoting vascular endothelial dysfunction and thrombotic process through oxidative stress. We previously found that PFO closure may reduce total homocysteine level (tHcy) in plasma. Here, we compare the effect of PFO closure and medical treatment in reducing mild homocysteinemia in PFO-related stroke patients. Methods Used 28 PFO-related stroke patients with mildly elevated tHcy (>12 mmol/l) were prospectively recruited in accordance with IRB. 14 received PFO closure and 14 were treated by medical therapy (antiplatelet/anticoagulant) alone. None of the patients were on folate or vitamin B supplementation. Plasma was collected at baseline and 1 year follow-up after treatment. tHcy level was determined by selected reaction monitoring using mass spectrometry. Summary of Results Compared to medical therapy, PFO closure resulted in a lower tHcy level during follow-up (PFO closure: 11.13±3.94 mmol/L, medical therapy: 15.48 ±3.55 mmol/L, p=0.006), with no difference at baseline (PFO closure: 17.77±4.39 mmol/L, medical therapy: 16.47 ±7.50 mmol/L, p=0.575). Mild hyperhomocysteinemia patients post PFO closure had a significant reduction of tHcy by 37.34% ( p=0.0005), with 71.43% of the patients (10 of 14) having tHcy levels back to normal (<12 mmol/l), while most of medically treated patients (13 of 14) stayed abnormal ( p=0.4820) (χ 2 -test, adjusted p=0.002). Conclusions We found that compared with routine medical therapy, PFO closure reduced tHcy level in patients with mild hyperhomocysteinemia. Since PFO stroke patients tend to be younger, the life-time risk of even mildly elevated tHcy may be important for future thrombotic risk. Understanding the mechanism of PFO-related tHcy changes is important in optimizing medical treatment (e.g, folate replacement); studies are ongoing. Purpose of Study To determine whether genetic rather than environmental factors may be responsible for the occurrence of these neoplasms in families. Methods Used We interrogated our registry of >700 pedigrees of families (fams) with multiple hematologic malignancies. We identified 31 fams with both NHL and MM in their pedigrees. In 16 pedigrees a parent and child were affected (12 father-child pairs and 4 mother-child pairs). Fifteen affected sib pairs were identified in the 31 fams, 10 same sex pairs and 5 male-female pairs. Six of the 31 pedigrees had only 1 affected pair. More distant relationships were observed in other fams.
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Summary of Results
Moderated
MP6 HOMOCYSTEINE LEVEL IN PFO RELATED STROKE PATIENTS WITH RESPECT TO MEDICAL THERAPY VS PFO CLOSURE
W
MP7 FAMILIES WITH BOTH NON-HODGKIN
Summary of Results
Male transmission was evident in 25 fams and female transmission was observed in 6. NHL and MM cases had at least 1 unaffected generation (gen) between them in 8 pedigrees, and the diseases occurrred in sequential (13 fams) or the same gen in 10 fams. MM was the diagnosis (dx) in the youngest affected gen in 9 pedigrees, NHL in 13 pedigrees and both occurred in the youngest gen in 9 fams. The median age at dx of 29 NHL patients for whom data were available was 55 yrs (range, 20-99 yrs), and the median age at dx of 26 MM cases was 56 yrs (range, 30-82 yrs). Ten of 26 MM patients were <50 years old at dx. The presence or absence of anticipation could be assessed in 15 of the 31 pedigrees. All 15 displayed anticipation in terms of succeeding gens developing NHL or MM at an earlier age than did the previous gens (median −19 yrs, range −6 to −56 yrs). Conclusions We demonstrate anticipation in 15 assessible fams with both NHL and MM, a feature of familial MM that we previoiusly reported (Despande HA, et al: Br J Haematol 1998). More advanced, aggressive disease at dx in the youngest gen is another feature of anticipation, and was observed in 9 of 13 fams in which it could be assessed. Demonstration of anticipation in all 15 evaluable fams suggests a genetic basis for the relationship between these two B-cell disorders. The increase of same sex sib pairs among affected sib pairs implicates a locus on a pseudo-autosomal region of the X chromonsome as potentially responsible for this observation, as we have previously reported for Hodgkin's lymphoma (Horwitz M, Wiernik PH, Am J Hum Genet 1999). Myeloma and non-Hodgkin's lymphoma may have common genetic causation; molecular studies of these fams are planned. Purpose of Study Serum protein electrophoresis (SPEP) with subsequent immunofixation (IF) are clinical laboratory techniques used to evaluate a wide-range of disorders where abnormal serum protein quantities are characteristic (e.g. multiple myeloma (MM), MGUS, amyloidosis, HIV/ AIDS, SLE, CLL/NHL). Thus, it is important to identify or exclude malignancy when considering the analyses. Our aim is to characterize SPEP patients from our institution, a predominantly black population. Methods Used We retrospectively reviewed 50 patient's SPEP/IF results. Data recorded were SPEP/IF results, monoclonal immunoglobulin (Ig) identity, clinical diagnoses, age, race and gender. Univariate analysis was used to describe patient demographics. Parametric analysis was used to compare the monoclonal gammopathy (MG) group versus non-MG group. Summary of Results Age range was 12-86 years, mean age was 62 years and male to female ratio was 1:3.5. Forty-eight (96%) patients identify as black, 1 (2%) Asian Abstract MP6 Figure 1 and 1 (2%) white. SPEP patterns showed 1 (2%) patient had acute inflammation, 3 (6%) had chronic inflammation, 24 (48%) were inconclusive, 16 (32%) had MGs, 3 (6%) had normal results and 3 (6%) had polyclonal bands (table 1) . Among MG patients, IgG was most common isotype (75%), kappa was most common light chain (58%) and IgG kappa was most common (44%). Mean age was 69 years for MG patients and 58 years for non-MG patients.
MP8 MONOCLONAL GAMMOPATHY CHARACTERIZATION USING SERUM PROTEIN ELECTROPHORESIS IN A MAJOR URBAN POPULATION
MM was identified in 9 (18%) patients; 89% (8/9) had normal total protein (TP) levels and 1 (11%) had increased TP. Neuropathy was seen in 7 (14%) patients; 71% (5/7) had polyclonal gamma Ig increase, and 1 (14%) case with co-HIV infection had monoclonal IgG kappa. Seven (14%) patients had CKD, 4 (8%) had HIV/AIDS, 3 (6%) had anemia, 3 (6%) had MGUS, 1 (2%) had SLE and the remaining 16 (32%) had other co-morbidities (i.e. HTN, DM, CAD, etc.). Conclusions SPEP/IF analyses were used to characterize 50 patients. A wide-range of disorders were observed. MG patients were 11 years older than non-MG patients. IgG kappa was most common MG. Our study showed femalepredominance. This study shows SPEP utility to discern various disorders observed at our institution. Purpose of Study Up to 80% of asthmatic children may experience upper airway symptoms, including rhinitis, often perceived as coming from lower airways. Asthma diagnosis, classification and assessment of control are defined by the National Asthma Education Prevention Program (NAEPP) 2007 guidelines, but may understate the impact of the upper airway. We explored associations between Sino-Nasal 5 (SN-5) quality of life questionnaire, validated in radiographic confirmed sinus disease, and NAEPP asthma impairment in children. We hypothesize that children with NAEPP defined uncontrolled asthma will have abnormal SN-5 scores. Methods Used We performed a retrospective chart review of children (1-21 yr) referred to a pediatric pulmonary clinic for persistent asthma. Data collected include age, gender, BMI%, NAEPP asthma severity, SN-5, asthma control (TRACK children <5 y, ACT children ≥5 y) and pulmonary function testing (PFT). The primary analysis was to identify associations between SN-5 scores and levels of NAEPP guideline impairment: daytime symptoms, night time awakenings, activity interference and PFTs. Significant SN-5 scoring was defined as ≥3.5 based on prior studies. PFT was performed in children ≥5 y. Statistical analysis with SPSS 22. Summary of Results 76 children were evaluated; 38% female, mean age 6.9 y and mean BMI% 69%. Significant SN-5 score (≥3.5 vs. <3.5) was associated with decreased control of daytime symptoms (OR 0.16 ). Those with SN-5 ≥3.5 had poor asthma control based on TRACK ( p<0.002) and ACT ( p<0.001). Age, gender, BMI%, asthma severity and PFTs were not associated with SN-5. Conclusions In persistent asthmatic children, NAEPP defined daytime, night time, activity related impairment and poor asthma control were associated with a significant SN-5 score; PFTs and NAEPP asthma severity were not. This suggests that upper airways may play a larger role in lower airway associated symptoms, and that SN-5 may be beneficial in assessing asthma symptoms. Recognizing and treating upper airway symptoms, an understated area in asthma guidelines, might improve overall asthma control. A prospective analysis in a larger cohort is recommended to evaluate these findings. Purpose of Study Shenhav et al. (2011) found that individual analytical style (reflective vs. intuitive) predicts belief in God or a higher power. Although intuitive thinkers are more likely to have strengthened religious beliefs since childhood, there is no correlation between analytical style and familial religiosity during childhood. This study examines the hypothesis that the link between intuitive thinking and religious belief is part of a broader preference for teleological explanations. We also test a possible mechanism responsible for teleological endorsement: intuitive thinkers may endorse teleological explanations because they confuse causal directionality. Methods Used A questionnaire comprised of a randomized series of stimuli was administered via Amazon Mechanical Turk. Stimuli included the Cognitive Reflection Test (CRT; Frederick, 2005) to determine analytical style, questions on conditional probability to judge causal reasoning (Kahneman & Tversky, 1977) , and a series of true or false questions on various teleological statements (Kelemen et al., 2013) . Participants were then asked to rank on a scale from 1-7 the extent to which they believe in the existence of God or a higher power, and the extent to which they believe such a higher power influences events in the world (agency). Statistical analysis was performed using Spearman correlation. Summary of Results As expected, teleological endorsement levels positively predicted belief in agency of a higher Abstract MP8 Figure 1 power (R=0.28, p<.01) and CRT score negatively predicted teleological endorsement levels (R=−0.24, p<.01). However, no significant correlation was found between CRT performance and tendencies in responding to conditional probability stimuli (R=0.017, p=0.85). Individual belief in agency of a higher power predicts teleological tendencies to a greater extent than religious belief alone ( p=0.075) for belief in higher power, compared with p=0.085 for belief in agency of higher power. Conclusions Our results replicate previous findings that show a relationship between intuitive thinking and religious beliefs and suggest that this may reflect a general preference for teleological explanations. However, the reasons why intuitive thinkers endorse teleological explanations are still unclear. Purpose of Study Psoriasis is a chronic inflammatory disorder associated with vascular inflammation (VI), measured by 18-fluorodeoxyglucose positron emission tomography/ computed tomography (18-FDG PET/CT), and increased risk of MI. Patients with psoriasis are more likely to have comorbid depression and anxiety. Whether these comorbidities accelerate the development of CVD in psoriasis is unclear. We hypothesized that aortic VI and coronary plaque burden would be increased in patients with psoriasis who have depression and/or anxiety compared to those with psoriasis who do not. Methods Used Patients were prospectively enrolled. Those who reported a history of depression and/or anxiety (n=40) on survey and age-and gender-matched patients who reported no history of psychiatric illness (n=40) were selected. Target-to-Background ratio from 18FDG PET/CT was used to assess aortic VI, and coronary CT angiography scans were analyzed for coronary plaque composition. Summary of Results Both aortic VI and coronary plaque burden were higher in psoriasis patients with comorbid depression or anxiety compared to those without (table 1) Purpose of Study We report a case of early stage CLL that caused cryoglobulinemia-related glomerulonephritis (MPGN). This prompted a literature review to identify the incidence and causes of renal disease in patients with CLL. Methods Used Using a PUBMED search data of cases reported between 1990 and 2014, we selected cases with the following criteria: (1) Clinical and hematologic diagnosis of CLL (2) Evidence of renal insufficiency in association with CLL in the absence of other causes for proteinuria.
MP10 ANALYTICAL STYLE PREDICTS RELIGIOUS AND TELEOLOGICAL BELIEF
MP11 COMORBID DEPRESSION OR ANXIETY IS ASSOCIATED WITH AORTIC VASCULAR INFLAMMATION AND CORONARY HEART DISEASE BEYOND TRADITIONAL CARDIOVASCULAR RISK FACTORS IN PSORIASIS
Abstract MP11 Figure 1 Abstract MP12 Figure 1 IFE of cryoglobulins involving the kidney in our patient; predominantly IgG and kappa light chain (A&D) with weak expression of IgM lambda (B&D).
Summary of Results
Review of the literature revealed that 50 cases of CLL-related nephropathy have been reported, commonly with the nephrotic syndrome (MPGN). IHC staining of the renal biopsies of these patients revealed mostly monoclonal IgG kappa. Many of these were low stage CLL patients and had not been treated. In 68% the renal complications first developed years after the CLL was diagnosed. Most importantly, 65% of all patients' nephropathies responded completely to anti-CLL therapy. Conclusions We report a rare manifestation of a secretory type of CLL with cryoglobulinemic vasculitis; leading to rapid renal deterioration needing dialysis. Renal damage can be a sequela of early-stage CLL due to its secretory phenotype. Timely recognition of kidney impairment and routine testing of serum or urine proteins in CLL patients is warranted to detect its early transition to a secretory phenotype. We believe that therapeutic intervention in early stage CLL may be effective in the preservation of renal function by removing the secretory phenotypic clone. Purpose of Study IV tPA is not routinely followed by blood work due to its reputed short half life. While there has been much focus on tPA's extra-vascular effects on the neurovascular unit in the context of hemorrhagic transformation (HT), little is known about its intravascular efficacy, where it has its intended effect. Emerging data suggest that tPA may be most effective in microvasculature and IV therapy may be a good adjunct to intra-arterial therapy. We previously found that the effect of tPA can last more than 72 hr after stroke onset. Now, we report that even routine blood labs can potentially predict HT. Methods Used 72 storke patients with IV tPA were recruited on IRB approval. Clinical coagulation profile (PT, PTT, fibrinogen and D-dimer) were performed at 12, 24, 72 hr post tPA. Patients on medications (e.g. anticoagulants) or with conditions (e.g. liver dysfunction, infection) that may affect these labs were excluded. Summary of Results Compared to those without HT, HT patients had significantly higher PT and PTT (Fig A,B) as early as 12 hr post IV tPA and throughout the first 3 days of treatment. ROC analysis suggested PT/PTT at 12 and 24 hr has potential to predict tPA-induced HT (Fig C,D. PT: AUC=0.848, p=0.001; PTT: AUC=0.877; p=0.003). Conclusions Higher PT/PTT level within 72 hr of IV tPA is early marker of tPA-induced HT. Whether these routine labs have value in symptomatic hemorrhage will require further study in a larger cohort. But this proof-of-concept study suggests that tPA efficacy can potentially be followed in real time. The development of a reliable blood test would be of clinical utility to gauge thrombolytic efficacy in real time to guide and triage adjunct treatments. Purpose of Study Immediate cardiac catheterization is indicated for patients presenting with ST elevation (STE) myocardial infarction, and door-to-balloon time should be <90 min. Patients with non-ST elevation myocardial infarction (NSTEMI) can often be stabilized with medication, and only require urgent invasive evaluation if there is persistent chest pain(despite medical therapy) or hemodynamic or electrical instability. Immediate cardiac catheterization for patients presenting to the ER with chest pain is available in many hospitals, but it involves a large investment of resources which need to be properly utilized. This study evaluated patients sent for urgent invasive evaluation to determine how the facility is utilized. Methods Used In a retrospective chart review, charts from all STEMI code patients presenting between the dates 1/1/ 15-9/1/15 were studied. The presenting EKG was evaluated to determine whether STE criteria (as per ACC guidelines) were met. The charts were reviewed for angiographic Abstract MP13 Figure 1 Abstract MP14 Purpose of Study Over the years, epidemiology of infective endocarditis (IE) has been changing with the change in population at risk. The aging of our population, better antibiotics for treatment of infections and changes in predisposing conditions have contributed to the changing prevalence patterns of this disease in different patient groups. At present little data is available on the prevalence of IE in selected patient groups such as the medically indigent. We studied the prevalence of IE in patients evaluated in an inner city hospital. Methods Used We screened the clinical, laboratory and echocardiographic data of 246 consecutive patients referred for echocardiographic evaluation, with suspected IE during the period 04/1996 to 05/ 2001. Using the New Duke criteria for diagnosing endocarditis, these patients were classified as having 1. Definite IE 2. Possible IE and 3. Diagnosis of IE rejected. Summary of Results Of the 246 patients screened, 72 (29%) fulfilled criteria for diagnosis of IE. Twenty of these patients (8%) were classified as "definite" IE and 52 (21%) as "possible" IE. Diagnosis of IE was "rejected" in 174 (71%) of the screened patients. Conclusions Screening for IE in this medically indigent patient population of an inner city hospital, confirmed definite endocarditis in only 8% of the patients referred with suspected endocarditis. This represents a very small proportion of the patients screened and is much lower than reported in other studies, in a different patient population. This could be due to a higher degree of suspicion for IE in this patient group. Further inquiry is needed to confirm the underlying mechanism responsible for this observation. Purpose of Study Fibrocalculous Pancreatic Diabetes (FCPD) and Lean Diabetes (LD) are unique forms of diabetes affecting millions of people in developing countries, characterized by the presence or absence of pancreatic calcifications on ultrasound and insulin-requiring but ketosisresistant diabetes. To optimize therapeutic strategies for FCPD and lean diabetes patients, it is imperative to conclusively assess their insulin secretion using gold-standard methodologies. Methods Used Comprehensive tests were undertaken in n=22 Indian males with FCPD (age 30±2 y, BMI 19.7 ±0.6 kg/m2, HbA1c 9.0±0.3%) and n=6 with LD (age 36±4 y, BMI 18.3±0.1 kg/m2, HbA1c 11.6±1.3%), and compared with n=12 age, BMI matched ND, n=16 T1D (HbA1c 9.1±0.3%) and n=12 T2D subjects (age 36±2 y, BMI 26.0±0.3 kg/m2, HbA1c 9.7±0.6%). Following correction of hyperglycemia for over two weeks, mixed-meal tolerance tests (MMTT) and C-peptide deconvolution analysis was performed to assess beta-cell function. Summary of Results Glucose and C-peptide responses to MMTT suggest subjects with FCPD (14.5±2.2 pmol/kg/ min) and LD (15.0±2.9 pmol/kg/min) have markedly impaired insulin secretion relative to both ND and T2D ( p<0.001), and not statistically different from T1D (figure 1). Conclusions Thus, we report the first studies showing that patients with low BMI diabetes have impaired insulin secretion despite correction of hyperglycemia, consistent with nutritional effects on beta cell development or function.
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14 UNABLE TO BE PUBLISHED 10.1136/jim-2016-000080.30 Unable to be published. figure 1A ). In the 37 PFO patients treated with medicine alone, no changes were observed (BL: 5.79±7.15 mM; FU: 6.25±6.68 mM; p=0.4050) (figure 1B). 5-HT reduction was independently associated with PFO closure after adjusting for age, gender, medical history and medication status in a multivariate regression ( figure 1C) . Conclusions We found that PFO closure independently reduced 5-HT level in peripheral venous blood. These results support the hypothesis that PFO related right-to-left interatrial shunt may foster higher level of procoagulant and vascoactive substances in circulation. While PFO closure decrease prothrombotic markers immediately post closure, this effect is sustained in long term followup up to 1 year. Further studies on the clinical outcome of these PFO patients with respect to their prothrombotic circulatory profiles are ongoing. Purpose of Study Postpartum depression (PPD) occurs in up to 20% of mothers. The American Academy of Pediatrics recommends routine screening for PPD. The pediatric emergency department (PED) serves as a safetynet for vulnerable, high-risk populations, and may be a useful site for screening. This study investigates (1) prevalence of PPD positive screens, (2) factors associated with a positive PPD screen, (3) frequency of mothers who had not completed a PPD screen previously, and (3) acceptability and impact of PPD screening. Methods Used We performed a prospective, crosssectional survey of a convenience sample of mothers of infants </=6 months of age presenting with low-acuity complaints. Mothers completed a computerized survey that included a validated PPD screening tool (Edinburgh Postnatal Depression Scale). We calculated frequency of positive screens and performed bivariable logistic regression to identify factors associated with a positive PPD screen. PPD positive-screened mothers were contacted for phone follow-up at one-month. Summary of Results 121 mothers were screened for PPD (mean age=28± SD 6 years; 86% English vs. Spanish language; 50% non-Hispanic Black race/ethnicity; 75% nonprivate insurance) during presentation to the ED with their infant (mean age=3±SD 2 months; 51% female). Twenty-seven mothers (22%) screened positive for PPD with eight mothers (7%) reporting suicidal thoughts. Forty-seven percent (57/121) of mothers had never previously been screened, including 59% (16/27) of PPD-positive screened and those endorsing suicidal thoughts (5/8, 63%). Infants of PPD-screened positive mothers had more ED visits than those whose mothers screened negative (median 2 vs. 1). Seventy-four percent (90/121) of participants viewed ED-based PPD screening favorably. At one-month follow-up 100% (n=12) reported ED-based PPD screening acceptable and the majority endorsed positive impact of screening, including increased access to support (8/12, 67%) and improved activities of daily living (10/12, 83%). Conclusions PPD is reported by approximately 1 in 5 mothers in an urban PED and the majority of PED-screen positive mothers had not been screened previously. PED-based screening was well-accepted and had a positive impact. Our study informs future efforts for interventions to support mothers of young infants who use the PED for care. Purpose of Study Obesity is a major risk factor for difficult-to-control asthma. We reported obese visceral adipose-derived exosomes contain miRNAs capable of impairing TGF-β signaling, a pathway involved in airway remodeling, associated with poor asthma clinical outcomes. We hypothesized that adipose-derived exosomal miRNAs from obese youth with asthma would be associated with poor asthma control. Methods Used AsthMaP-2 Subjects (youth with physiciandiagnosed asthma) were selected at extremes of obesity (n=10) and leanness (n=10). We profiled RNA from adipose-derived exosomes from serum and urine and identified significant correlations ( p≤0.05) between obese adipose-derived exosomal miRNAs and Asthma Control Test (ACT) scores. Ingenuity Pathway Analysis generated predicted mRNA targets and pathways. Summary of Results Obese subjects had a BMI≥98th percentile and lean subjects had a BMI≤13th percentile for age and sex. Serum adipose-derived exosomes contained 12 ACT-correlated miRNAs predicted to target 2,963 mRNAs with TGF-β Signaling as the top pathway (ratio=36/87; p=3×10 −9 ). Urinary adipose-derived exosomes contained 7 ACT-correlated miRNAs predicted to target 2,387 mRNAs with TGF-β Signaling among the top pathways (ratio=18/87; p=0.01). The serum exosomal miRNAs were predicted to target TGF-β signaling mediators' mRNAs: downregulation of ACVR2B, SMAD3, SMAD5, and SMAD7 by miR-15a-5p (Fold Change (FC) =1.5; p=0.039) and upregulation of TGFB2 and TGFBR2 by miR-153-3p (FC=−1.7; p=0.041). The urinary exosomal miRNAs were also predicted to target TGF-β signaling mediators' mRNAs, the net effects were the opposite direction: upregulation of ACVR2B and SMAD4 by miR-138-5p (FC=−1.2; p=0.033) and downregulation of TGFB2 and TGFBR2 by miR-153-3p (FC=1.6; p=0.026) and SMAD6 by miR-3187-5p (FC=2.3; p=0.008). Conclusions Poor asthma control in obese youth is associated with adipose-derived exosomal miRNAs in both serum and urine, in particular those that are predicted to affect TGF-β signaling. Due to anatomic considerations, visceral adipose-derived exosomes are expected to predominate in urine, while serum will contain a mix of both visceral and subcutaneous adipose-derived exosomes. Therefore, adipose-derived exosomes derived from urine may be useful biomarkers in obese subjects with asthma. Purpose of Study Psoriasis (PSO), a chronic inflammatory disease associated with increased cardiovascular (CV) risk, provides a clinical human model to study inflammatory atherogenesis. While PSO severity is associated with both in vivo vascular disease and future CV risk, the longitudinal impact of PSO severity on coronary disease progression is unknown. We hypothesized that an improvement in PSO severity may lead to a reduction in coronary plaque burden by coronary CT angiography (CCTA). Methods Used Consecutively recruited PSO patients (N=50) underwent CCTA (320 detector row, Toshiba) and cardiometabolic profiling at baseline and 1-year follow-up. Total (TB) and non-calcified (NCB) coronary plaque burden were quantified using QAngio (Medis, Netherlands). PSO severity was measured as the psoriasis area severity index (PASI). The longitudinal change in coronary plaque burden was analyzed with unadjusted and adjusted regression. Purpose of Study Resveratrol is a plant-derived polyphenol whose beneficial metabolic effects in rodents include improved insulin sensitivity, reduced inflammation, and increased muscle mitochondrial biogenesis. We set out to confirm these findings in insulin resistant human subjects, by examining the effects of resveratrol on insulin sensitivity, muscle mitochondria, and adipose inflammation. Methods Used Specifically, resveratrol 2 gm/day (RV) or placebo (PL) were administered for 28 days in a randomized, double-blinded fashion to n=21 non-diabetic subjects (17 M; Age=52±2; BMI=31.9±0.9 kg/m 2 ; HOMA-IR=3.9±0.2). All subjects participated in 6-hour, stepped euglycemic hyperinsulinemic (30 and 80 mU/m 2 . min) 'pancreatic clamp' studies to assess hepatic and peripheral insulin sensitivity, with biopsies of vastus lateralis muscle and subcutaneous abdominal adipose tissue, before and after RV and PL. Muscle mitochondria were analyzed for quantity, size, area in a field, and the % area covered, using electron microscopy with Volocity image analysis. Summary of Results RV induced a 22% ( p=0.035) increase in glucose uptake, but did not affect glucose production. There were no changes in quantity ( p=0.829) or percent area ( p=0.897) of muscle mitochondria. There were no changes in basal or resting energy expenditure (Kcal/day) or respiratory quotient, as assessed by indirect calorimetry (Deltatrac), or in muscle strength in these healthy middle-aged subjects. However, RV reduced adipose tissue inflammation, with decreased expression of the pro-inflammatory cytokines TNFα and IL6 in whole fat (by 68% and 52%, p<0.05), and of IL6 and PAI-1 in adipose macrophages (by 50% and 40%, p<0.05). Adiponectin expression in whole fat increased by 53% with RV. Furthermore, we observed increased expression of genes associated with 'browning' of adipose tissue, including UCP1 and PGC-1α (46.6% and 34.9% increases, respectively). Purpose of Study The application of next-generation sequencing (NGS) technology has shown that microbial communities in the respiratory airways (i.e., the microbiome) play a significant role in the onset, development and severity of asthma. However, little is known about their temporal dynamics (i.e., microbial succession), which poses a significant obstacle to identifying pulmotypes of disease and assessing inter-patient variation. Here, we couple NGS and 16S rRNA data to characterize the nasopharynx microbiome of children with asthma and determine its stability over time. Methods Used We collected nasal washes from 40 children with asthma enrolled in the AsthMaP-2 Project from two consecutive visits, six months apart. Total DNA was extracted and sequenced for the 16S-V4 rRNA gene region (∼250 bp) using the MySeq Illumina platform. Reads were analyzed in Mothur using the SILVAv119 reference database. Alpha diversity metrics and phylogenetic and countbase distance community indexes of beta diversity were compared across samples and time points. PCoA and NJ clustering analysis were used to assess community relatedness. Differences in alpha diversity and OTU abundance between sample pairs across time points were also compared. Summary of Results A mean of 27,479 clean 16S sequences corresponding to an average of 173 OTUs were sequenced and detected per sample, respectively. Representatives of Moraxella, Corynebacterium, Prevotella, Staphylococcus, Alloiococcus, Streptococcus, Peptoniphilus, Fusobacterium, and Haemophilus accounted for 36 to 99% of the reads across samples. These genera have been previously found in the nasopharynx of asthmatic and healthy children. A total of 61 OTUs from these genera were present in at least 50% of the samples (i.e., the nasal core microbiome). Significant differences in core microbiome composition were detected between sample pairs, but no directional trend (increase or decrease) was observed across sample pairs. Samples were randomly ordinated and did not cluster together. Conclusions Our analysis of nasal microbiomes in 40 asthmatic children revealed significant differences in composition within individuals over six months. Future cross-sectional microbiome studies need to be aware of short span temporal dynamics in nasal microbiota. Purpose of Study Mitotic behaviors are likely important for maintaining and restoring homeostasis in lung diseases with epithelial injury. We recently proposed that regenerative asynchrony in repairing tissue may underlie chronic inflammation and fibrosis, where immune cell infiltration is secondary to pro-inflammatory cross-talk among asynchronously repairing adjacent tissues. Building on our previous finding that regenerative asynchrony is associated with pro-inflammatory/fibrotic cytokine secretion, here we provide proof of cause-and-effect. Methods Used In vitro experiments were performed wherein airway epithelial cells were mitotically asynchronous due to disease state and then resynchronized via capture of the G 1 /S checkpoint via pulse exposure to dexamethasone, simvastatin, or aphidicolin. Experiments utilized a novel method we developed for inducing mitotic asynchrony in normal progenitors. Induced populations were used to elucidate if TGF-β1 plays a role in the resynchronization process. Summary of Results Human asthmatic fully-differentiated air-liquid interface airway epithelial mitosis was asynchronous relative to normal epithelia. Mitotic capture increased the percentage of progenitors in G 1 . This resynchronization in the asthmatic epithelia reduced basolateral TGF-β1 secretion. We next examined whether inducing mitotic asynchrony in normal epithelial cells would result in TGF-β1 secretion. Mitotic asynchrony was induced and samples showed moderate asynchrony at 6 and 12 hours that resolved spontaneously by 48 hours. These cells show elevated TGF-β1 secretion at 12 hours compared to either cell population in isolation. Regulation of TGF-β1 is being investigated as a possible mechanism for synchronization through contact and non-contact dependent experiments. Additionally, blocking TGF-β1 delays resynchronization. Conclusions Cumulative analysis shows mitotic synchrony is the homeostatic state in airway epithelial progenitor populations and poorly-synchronized mitosis (as in asthma) induces TGF-β1 secretion and a pro-inflammatory/profibrotic airway. This finding establishes rationale for targeting progenitor cell mitotic behavior rather than immunemediated inflammation in fibrotic disease.
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OBESE ADIPOCYTE-DERIVED EXOSOMAL MIRNAS TARGETING TGF-β SIGNALING ARE ASSOCIATED WITH POOR ASTHMA CONTROL
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IMPROVEMENT IN PSORIASIS SKIN DISEASE SEVERITY IS ASSOCIATED WITH REDUCTION OF CORONARY PLAQUE BURDEN
Summary of Results
VASCULAR INFLAMMATION AND AORTIC WALL CHARACTERISTICS MODULATE FOLLOWING LIFESTYLE CHANGES IN PSORIASIS PATIENTS AT 1 YEAR FOLLOW UP
A Joshi,* P Shukla, TM Aberra, JB Lerman, B Natarajan, Q Ng, J Silverman, J Rodante, NN Mehta. National Heart, Lung and Blood Institute, Bethesda, MD, United States 10. 1136/jim-2016-000080.39 Purpose of Study Psoriasis (PSO), a chronic inflammatory skin disease, is associated with increased CV risk and vascular inflammation (VI). However, the effect of therapeutic lifestyle changes (TLC) including exercise on VI over time is unknown. We hypothesized that TLC would lead to an improvement in VI at 1 year accompanied by improvements in aortic wall characteristics. Methods Used 65 PSO patients, recruited consecutively, underwent FDG PET/CT, phase contrast MRI scans and clinical visits for evaluation of VI, wall characteristics and exercise frequency, at baseline and 1 year follow-up. VI was measured as Target-to-background ratio (TBR), and aortic distensibility (AD) and wall thickness were assessed by commercial software on phase contrast MRI scans. Clinical parameters were ascertained by both survey and provider. Summary of Results VI decreased at 1 year (6.5% decrease in TBR; p<0.0001), and was inversely associated with exercise frequency beyond adjustment for CV risk factors (β=−0.27; p=0.001). Furthermore, this decrease in VI was associated with improvement in AD (40% increase; p<0.001) and aortic wall thickness (8.5% decrease; p<0.001). Conclusions Our findings suggest that VI improves with TLC. This 6.5% decrease in VI could lead to ∼30% reduction in future adverse events, based on a recent large prospective study. This VI reduction is also associated with improved aortic wall characteristics suggesting that targeting VI as a surrogate marker holds promise to understand the effects of TLC on CV disease. Purpose of Study Cocaine-related chest discomfort is frequently encountered in urban emergency departments. Incidence of co-morbid illness and heart disease is not well defined in patients with cocaine-related ACS. Appropriate risk stratification in patients with cocaine-related ACS is not clearly defined. Methods Used 231 consecutive patients meeting inclusion criteria were entered into a large ACS registry at an urban, inner-city acute-care facility. Comparisons in demographics, co-morbid conditions, left ventricular function and coronary disease were made between patients with cocainerelated ACS and those with non-cocaine ACS. Summary of Results 44 (19%) of these patients either tested positive for cocaine by urine drug screen or had selfreported cocaine abuse. Compared to the non-cocaine ACS patients, these individuals were significantly younger, more likely to be male, unmarried, uninsured and also have history of alcohol and tobacco abuse (all p<0.05). The cocaine-users were less likely to have risk factors of diabetes (p<0.002) and hyperlipidemia ( p<0.02). Ejection fraction mean was 51.3% (sd 15.4) in the cocaine-users vs. 48.1% (sd 14.0) in the non-cocaine users, with an incidence of EF</=40% of 28% vs. 31% respectively ( p=ns). 50% (22/44) of the cocaine-users underwent a stress test evaluation, and 27% of these were positive for ischemia. Of the 41% (18/44) undergoing cardiac catheterization, 13/18 were diagnosed with significant CAD, 4/18 with non-ischemic cardiomyopathy, and one study was normal. A total of 24/44 (55%) had either a new or old diagnosis of documented CAD or NICM, compared to 94% of the non-cocaine ACS patients. Conclusions Cocaine-related chest pain leading to hospitalization is often associated with infarction or significant coronary artery disease. Although optimal evidence-based management is lacking in this population, ischemia evaluations and appropriate further risk stratification and modification may be warranted. Purpose of Study Cardiac acetylcholine (ACh) signaling is protective, but the role of ACh in ischemic preconditioning (IPC) remains largely unknown. We studied the effect of selective alpha-7 nicotinic ACh receptor (a7nAChR) antagonism by methyllycaconitine (MLA) on the functional benefits of IPC and the effects of this on mitochondrial complexity and inner mitochondrial membrane potential (ψM). Methods Used Male Sprague Dawley rats (n=17, 322± 17 g) were heparinized and anesthetized with 80 mg/kg pentobarbital IP, and their hearts excised and perfused at constant pressure with a non-circulating Langendorff apparatus. Left ventricular (LV) pressure (LVDP) and heart rate (HR) were continually measured with a fluid filled latex balloon attached to a pressure transducer. Treatment groups were: ischemia-reperfusion (IR)(n=6): 20 min. perfusion, 30 min. of global ischemia, 45 min. of reperfusion; IPC (n=5): 10 min. perfusion, 3 min. ischemia with 2 min. reperfusion repeated 3 times prior to IR protocol, IPC+ MLA (n=6): 6 min. perfusion, 4 min. of infusion of MLA at 233 nM, IPC with MLA during reperfusion periods, then IR. Mitochondria were isolated from the LV free wall, stained for ψM and for size, and examined by Flow Cytometry with a BD LSRFortessa. Controls (C) (n=4) were freshly excised hearts from similar animals with identical anesthesia. Summary of Results IPC increased LV work product (LVDP times HR) as a percent of pre-ischemia (%P) during reperfusion compared to IR control, and this effect was attenuated by MLA pretreatment (IR=24.1±4.5%P, IPC=49.8±2.8%P, IPC+MLA=33.8±3.5%P, p<0.01). IPC reduced end diastolic pressure from IR levels, and this was partially prevented by MLA treatment (IR=78.8 ±7.7 mm Hg, IPC=18.8±6.6 mm Hg, IPC+MLA=46.3 ±8.6 mm Hg, p<0.05). IPC maintained mitochondrial structural complexity compared to IR (C=65±6% of total mitochondria, IPC=61±5%, IR=32±4%, p<0.01). MLA reduced the effect of IPC on ψM in intact mitochondria to IR levels (IR=67±10% of intact population, IPC=88 ±3%, IPC+MLA=71±4%, p<0.01). Conclusions Signaling through the a7nAChR is necessary for the effect of IPC on maintaining ψM and cardiac contractile function after IR injury. Purpose of Study Over 240,000 individuals are diagnosed with breast cancer each year in the USA. Outcomes depend on DNA deregulations in tumors. Carriers of deleterious BRCA1 and BRCA2 mutations are predisposed to 30 fold higher lifetime risks of breast and ovarian cancer. Aims: 1. To check for differences in SNPs of genomic DNA obtained in BRCA+/− with and without BrCa. 2. Analyze correlates of molecular mechanisms occurring in BRCA mutant patients.
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Methods Used
We analyzed 94 subjects (41 BRCA positive) with or without BrCa to detect SNPs whose expression is significantly differentially expressed between breast cancer and controls. DNA samples were extracted from PBMCs. Samples were measured for DNA concentration using an Invitrogen QuBit Fluorometer, and diluted to 50 ng/mL.
All samples were collected between 2010 and 2014 and survival data was known in all cancer patients. Processed samples were sequenced using an Illumina MiSeq Sequencer with a 300 cycle kit to detect SNPs. Variant Call Files were analyzed in Microsoft Excel using Fisher's Exact Test. Summary of Results ALK SNPs were commonly found in cancer relative to control. Significant associations of ALK SNPs were seen in BRCA mutation subjects. ALK protein was overexpressed in 47% of BRCA mutations cases, which was significantly higher than in non-BRCA cases. Our results show that the ALK signaling pathway possibly is more common in early onset of breast cancer as seen with BRCA mutations. Coremine analysis showed SNPs identified in cancer were most commonly associated with deregulation of Transforming Growth Factor-Beta Superfamily protein synthesis and binding function. Conclusions Differences in the associations of the modifying polymorphisms with BrCarisk for BRCA1 and BRCA2 mutation carriers are likely to reflect differences in the biology of tumor development in these two groups of women at high risk of breast cancer. The identification of modifying polymorphisms could therefore lead to a better understanding of the etiology of tumors in mutation carriers and also to the development of effective and more specific therapies for BrCa in mutation carriers. Purpose of Study Little is known about the disease burden for children and families of children with Basal Cell Carcinoma Nevus Syndrome. Our study focused on bringing this burden to light. Methods Used Using an internet accessible survey, we asked parents and guardians about the ways in which BCCNS has affected their families. The survey was promoted through the Basal Cell Carcinoma Syndrome Life Support Network to its membership, as well as through social media. Forty-seven parent/guardians responded. Summary of Results It was found that at least 75% of children were diagnosed with BCCNS by the age of ten or earlier, which suggests that the burden of disease starts much earlier than previously reported. Moreover, at least 19% of parents or guardians reported that their children had 50 or more BCCs by the age of diagnosis.
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BURDEN OF PEDIATRIC BASAL CELL CARCINOMA NEVUS SYNDROME ON THE PATIENTS AND FAMILIES FROM THE PERSPECTIVES OF PARENTS AND GUARDIANS
Sixty-percent of patients must see five or more healthcare specialists within one calendar year, and 33% of children must go see a healthcare provider (of any specialty) 8-10 times within one calendar year. Conclusions It is our hope that these results will help clinicians be aware of the possible diagnosis of BCCNS at earlier ages in these children. An earlier diagnosis could provide the social and medical specialty-specific support services that may prevent the development of psychosocial and other medical consequences that arise from the burden of disease of BCCNS. Purpose of Study Over 240,000 individuals are diagnosed with breast cancer (BrCa) of which 12,000 individuals carry BRCA germline mutations. MicroRNA dysregulation is common in malignancy and may correlate with germline mutations. Aims: 1. Analyze microRNAs in patients with breast cancer with or without BRCA germ line mutations, with and without cancer. 2. Identify molecular BRCA mutant patients to deduct reasons for accelerated malignancy. Methods Used We analyzed plasma miR expression from 94 br cancer patients (41 BRCA positive) relative to 24 normal controls. All samples were collected between 2010 and 2014 and survival data was known for all cancer patients. TaqMan Open Array panel was used to simultaneously run hundreds of microRNA assays in the Applied Biosystem Open array real time PCR. Using AB open array real time PCR, 756 miRNA species were detected. Two-sample t-test was used for all 2-sample comparison and ANOVA followed by Tukey HSD post-hoc test to compare the miRs mean differences. All tests were 2-tailed and results with a p<0.05 were considered statistically significant. Summary of Results BRCA+underexpressed hsa-mir-10a and hsa-mir-376c and over-expressed Hsa-mir-326 and Hsa-mir-143 relative to BRCA-; p<0.05.
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Using Coremine data mining linking genes and diseases differentially expressed circulating miRs are linked to tumor suppressor TGFbeta/SMAD3. Conclusions The early onset of breast cancer in BRCA mutant patients may recapitulate the pro-oncogenic effects of TGF-β. The context dependent SMAD3 binding & tumor suppression TGF-β effects are abrogated in BRCA mutant patients. TGF-β/Smad3 tumor-suppressor signature suppresses local inflammation in the tumor microenvironment. Purpose of Study Black women with triple negative breast cancer have 46% lower survival rates attributed to differences in tumor biology. We analyzed presurgical plasma microRNA of white (W) and black (B) women with TNBC enrolled in our breast ovarian tissue bank between 2004 and 2014. Aims Detect microRNA patterns in pre-surgical plasma of TNBC W or B Analyze differences by integrated approach to detect pathways differentially activated in the two groups. Methods Used Between 2004 and 2014 we investigated patterns of plasma miRNAs collected before, after surgery, during and after chemotherapy in 67 patients presenting for surgery for breast cancer (W=44 & B=44) and 25 age and race matched normal controls. Two-sample t-test was used for all 2-sample comparison and ANOVA followed by Benjamin Hochberg post-hoc test to compare the mean response between subject factors of interest. All tests were 2-tailed and results with a p<0.05 were considered statistically significant. Coremine was used to identify datasets in breast cancer microarray with emphasis on our differentially expressed circulating miRs. Summary of Results Mean age cancer 48 (range 35-78), control 44 (range 35-67): B patients did not express over 70% of pre-surgical plasma miRs over-expressed in the W pre-surgical plasma. Black patients had lower expression of . Samples from white patients overexpressed miRs−126, −150-5p, −142-3p; −30c-5p, −186-5p, 139-5p compared to healthy controls. These miRs significantly suppressed in blacks p<0.05.
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Coremine text mining suggests differentially regulated microRNA are involved in mitochondrial quality control and biogenesis. Conclusions Deregulation in circulating miRs between B and W patients point to pathways involved in mitochondrial fission and fusion. Aberrant mitochondria biogenesis was reported as mechanism for cancer stem cell survival and detrimental to innate immunity. Such pathways could explain the lower survival seen in black breast cancer patients. Purpose of Study The World Health Organization (WHO) and Toronto Public Health (TPH) performed a systematic literature review to identify predictors for different risk categories for postpartum depression (PPD). This review did not include patients in the pediatric emergency department (PED) setting. This study determines if the predictors identified in the WHO/TPH review are associated with positive PPD screens in an urban PED. Methods Used We performed a prospective, crosssectional survey of a convenience sample of mothers presenting with low-acuity triage level infants </=six months old to a PED. We calculated frequency of positive PPD screen predictors and performed multivariable logistic regression to identify association with a positive PPD screen. Summary of Results 121 mothers were screened for PPD during presentation to the PED with their infant; 27 (22%) screened positive. Adjusting for maternal age, race/ethnicity, and insurance status, WHO/TPH "strong" predictors of a previous history of depression (aOR 6.7; 95% CI 1.6, 28.6), a previous history of anxiety (aOR 16.1; 95% CI 2.1, 125.5), depressed mood or anxiety during this pregnancy (aOR 25.6; 95% CI 6.7, 98 .2), a recent stressful life event (aOR 5.4; 95% CI 1.9, 15.2), and lack of social support (report that they did not have someone they could count on to help with the baby; aOR 6.5; 95% CI 1.6, 26.9) were significantly associated with a positive PPD screen. "Moderate" predictors of infant fussiness, (all/most of the time; aOR 8.4; 95% CI 2.0, 35.3) and high levels of childcare stress (all/most of the time; aOR 4.6; 95% CI 1.7, 12.4) were significantly associated with a positive screen. "Small" predictors of quality of relationship with the partner (sometimes vs. all/most of the time having a good relationship with the partner; aOR 3.8; 95% CI 1.0, 6.3) was significantly associated; obstetric and pregnancy complications and socioeconomic status were not significantly associated. Our study was consistent with the WHO/TPH review which found no association of PPD with ethnicity, maternal age, education level, parity, or gender of the child. Conclusions Results in this urban PED are largely consistent with WHO/TPH predictors of PPD developed in other settings. Understanding PPD predictors can help physicians to improve screening and identification of PPD positive mothers. Purpose of Study Thrombocytopenia during chemotherapy is not always due to myelosuppression. We report an unusual case of isolated acute thrombocytopenia after oxaliplatin and irinotecan administration. We reviewed 11 reported cases to better understand the nature of the presentation and variability in response to treatment. Case Report Patient is a 63 year old female with metastatic colon cancer treated with palliative chemotherapy with FOLFOX. Follwing her 14th cycle she had an episode of acute drop in platelet count to 8,000/microliter. Peripheral smear revealed no evidence of thrombotic microangiopathy. She was managed with supportive platelet transfusions with slow recovery of platelet count. Subsequently she was treated with second line chemotherapy with FOLFIRI. Following the first cycle of Irinotecan, she again had a catastrophic drop in platelets from 136,000/microliter to 6,000/microliter within 10 hours. Due to this recurrent episode, a drug mediated thrombocytopenia was suspected and work up was initiated. She was initially treated with dexamethasone without a significant response. Platelet count normalized after 7 days with supportive platelet transfusions. Methods Used Blood was tested for drug dependent platelet antibodies by Flow Cytometry at the Platelet and Neutrophil Immunology Laboratory at the Blood Center of Wisconsin. Summary of Results The patient's serum showed evidence of drug dependent platelet antibodies to both oxaliplatin and irinotecan. Conclusions Drug mediated immune thrombocytopenia is not uncommon. Time to severe acute thrombocytopenia and platelet recovery time varied post exposure of the drug. It is unclear whether steroid or IVIG administration had any effect on the platelet recovery time. Recovery from thrombocytopenia was observed in all 11 cases after the discontinuation of the insulting agent. Confirmation of the presence of drug dependent platelet antibodies against the chemotherapeutic agent by flow cytometry essential for diagnosis. This would be the first reported case of acute thrombocytopenia to two different chemotherapeutic agents in the same patient. Whether the reaction is two different mechanisms or if there is a cross reactivity between Oxaliplatin and Irinotecan has yet to be investigated. 10.1136/jim-2016-000080.49 Purpose of Study This study will discuss the pathogenesis of sepsis, procalcitonin as a diagnostic prognostic marker for sepsis, other biomarkers of sepsis and sepsis treatment. Methods Used as required. Summary of Results Sepsis is a systemic immune response to infection by microbial organisms. Its complications are one of the leading causes of mortality. Mortality rate in sepsis remains high despite the current advances in medical science. Serum biomarkers like procalcitonin may aid in the early diagnosis of sepsis and therapeutic intervention. Procalcitonin belongs to a class of molecules, called "hormokines," given the hormonal origin of the protein and the inflammation-related functions of its propeptides. Procalcitonin is a potent amplifier of the inflammatory cascade. It has shown that it induces pro-inflammatory like effects on leukocytes (increased the expression of surface markers), increases leukocyte-derived cytokines and also augments nitric oxide. Procalcitonin was found to be a more accurate diagnostic parameter for sepsis. A systemic review and meta-analysis revealed that procalcitonin has a mean sensitivity of 77% and specificity of 79%. Elevated level of procalcitonin was found to be a better predictor of mortality and identify patients at higher risk of adverse outcomes.Procalcitonin is found to be superior to C-reactive protein, TNF-α, Interleukins and Lactate levels in terms of accuracy at identifying sepsis and assessing the severity of sepsis. Implementation of a procalcitonin-guided antibiotic therapy in clinical setting was associated with a reduced duration of antibiotic therapy in septic patients without compromising clinical or economical outcomes. Conclusions Procalcitonin has been proved to be more reliable biomarker in diagnosing sepsis and predicting clinical outcome. Integrating use of procalcitonin in the early golden hours of sepsis diagnosis and antibiotic stewardship program would be beneficial.
P9
THE ROLE OF PROCALCITONIN IN SEPSIS
This review identified the association of procalcitonin and sepsis. There is still a need for better understanding of how procalcitonin fits in the immune response, therefore further studies should be towards exploring the immunological role of procalcitonin in sepsis. Purpose of Study Autoimmune hemolytic anemia (AIHA) is a common phenomenon in Chronic lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) accounting for about 4-7% of cases. AIHA is commonly associated with certain conventional chemotherapy agents used in CLL/SLL. Ibrutinib, bruton tyrosine kinase inhibitor is category 1 indication for high risk (del 17p) and relapsed/refractory CLL. Literature review reports 11cases of Ibrutinib associated AIHA.
We report a case of AIHA precipitated by Ibrutinib in an high risk CLL patient, with prior history of AIHA. Methods Used Patient is an 81 year old black man diagnosed with asymptomatic Stage I CLL (del 17p) in 2010 and was on active surveillance. He developed AIHA in 2012, with good response to steroids and Rituximab. Subsequently he received 8 cycles of rituximab for symptomatic CLL with resolution of symptoms. In 9/2014, noted to have progression of disease with worsening B symptoms, leukocytosis and lymphadenopathy. He was started on Ibrutinib 420 mg PO daily with regression of lymphadenopathy within 3 weeks of therapy, but presented with symptomatic anemia with hemoglobin of 3 gm/dl, positive direct Coomb's test, elevated reticulocyte count and LDH consistent with AIHA. WBC elevated at 360 K/ uL from baseline of 150 K/uL and hemoglobin fell to 3 g/dl from 10 g/dl since Ibrutinib was initiated. Ibrutinib was held and patient received high dose prednisone followed by IVIG and cautious transfusion with minimal improvement in hemoglobin. Hemoglobin slowly up trended with weekly Rituximab and high dose steroids and remained stable around 10 gm/dl after 4 weeks of Rituximab. Ibrutinib was subsequently restarted with overall clinical improvement. Summary of Results In our patient, occurrence of AIHA falls in between 2-4 weeks as other reported cases suggesting that Ibrutinib could be a likely precipitating factor. Conclusions Review of data, reveals that 22% of patients had history of AIC prior to Ibrutinib, however occurrence of AIHA on Ibrutinib seems to be less common (0.7%). Mechanism of action of Ibrutinib associated cytopenias remains unclear. It was hypothesized that it may be due to IL-2 induced kinase inhibition by Ibrutinib, and needs further investigation. Purpose of Study ATL is a rare and aggressive peripheral T-cell neoplasm characterized by clonal human T-cell lymphotropic virus type-1 (HTLV-1) proviral DNA integration with host T lymphocytes.These patients commonly present with lymphadenopathy, skin rash, fever, fatigue or altered mental status. The prevalence of CNS disease varies from 3 to 50% and is always in the presence of systemic disease. Isolated cranial neuropathy as a presenting symptom has not been described in literature. Methods Used Retrospective chart review and review of literature. Summary of Results 49 year old Caribbean male presented with 2 month history of left sided headache, 5 weeks of right sided jaw numbness and pain which progressed to contralateral side. He was now unable to smile and had food falling from the side of his mouth. He denied fever, fatigue, night sweats, rash, weakness or abnormal lumps. Purpose of Study In both FOLFOX and FOLFIRI regimens used for colorectal cancer, the 5-FU is infused over 46 hours every 14 days. Given the 10-20% risk of neutropenic fever, these regimens may be given with pegfilgrastim support. There is evidence to support its use for 21 day cycles, but no phase III trials demonstrating its efficacy and safety for regimens given every 14 days, a potential concern, given the hypothesis that the hematopoietic stem cells mobilized by pegfilgrastim into the peripheral blood may undergo cell cycle arrest, apoptosis and death while under effect of chemotherapy. Pegfilgrastim regulates the proliferation, differentiation, and survival of the myeloid lineage. It mobilizes hematopoietic progenitor cells in the peripheral circulation, has a long half-life, and is given on day 4 of 14-day infusional 5-FU based regimens. Given the fact that cytotoxic chemotherapy is administered on day 11 after pegfilgrastim, we performed a retrospective study evaluating the correlation between decrease in complete blood count and chemotherapy administered at 11 day intervals after pegfilgrastim. Methods Used The medical records of colorectal cancer patients were reviewed from [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] Purpose of Study Hidradenitis Suppurativa (HS) is a chronic disorder involving apocrine glands characterized by comedo like follicular occlusion and a chronic relapsing inflammation; sinus tracts and scarring. We observed a case of HS in a young African American (AA) male with relapsing polyarthritis. Methods Used The patient first developed HS as a teenager and then arthritis 10 years later. On this presentation he had multiple nodular skin lesions, predominately in intertriginous areas in the axilla and inguinal area; few of them presenting as draining pustules which had increased in size and number as well as generalized arthritis. This occurs 1-2 times yearly subsiding in association with antibiotic treatment. Physical examination was notable for generalized suppurate nodules chronic scars and sinuses. Joint examination revealed generalized polyarthritis with effusions in ankles, knees and elbows. Laboratory evaluation revealed marked inflammation. Autoantibody studies were negative. Radiographs revealed demineralization, erosions including the distal interphalangeal joints with suggestion of pencil/cup deformity in an asymmetric manner. All cultures were negative. Urine Chlamydia and Neisseria polymerase chain reaction testing was also negative. Summary of Results Musculoskeletal association with HS has been reported. Most note an association of skin flares and that it tends to occur years after the onset of skin disease. Most reports are anecdotal. We identified one multicenter analysis. The pattern of disease described resembles the spondyloarthropathy manifestations including sacroiliitis, dactylitis, inflammatory back pain and entesthitis. Our patient's findings were consistent with the limited literature available. Conclusions In conclusion, we propose that inflammatory spondyloarthropathy may be a complication of HS. Purpose of Study CT-guided transthoracic lung biopsy (CTLB) is a widely used procedure for the diagnosis of pulmonary lesions. Complication of air embolism has an incidence of 0.02%-0.06%. We report a fatal case of air embolism in the left atrium as a consequence of CTLB. Methods Used A 82 years old white female who presented to the radiology department for further evaluation of a recently diagnosed right lung mass. Shortly following CTLB she became unresponsive and developed cardiopulmonary arrest. Cardio-pulmonary resuscitation (CPR) was performed according to ACLS guidelines. She was successfully resuscitation and admitted to the ICU.CT chest was performed immediately after resuscitation which showed frothy air dense material in the left atrium and one of the right pulmonary veins suggesting a Broncho venous fistula with air embolism. Patient was subsequently sent to hyperbaric oxygen chamber which she tolerated well. A repeat CT chest and head failed to depict any evidence of air embolism. She was successfully weaned from the mechanical ventilation and extubated the following day. Summary of Results Air embolism following CTLB has a reported incidence of 0.02 to 0.06 but has catastrophic consequences if diagnosis is not made in a timely manner. The amount of air entry into the system is directly proportional to the severity of the patients symptoms. The mechanism of air entry in our patient was secondary to iatrogenic bronchovenous fistula. Conclusions Despite such rarity and fatal complication, clinicians should be aware of systemic air embolus after lung biopsy and be ready to provide emergent management for the treatment of the patient. Purpose of Study Colonoscopies are a relatively safe and are associated with few complications. We present a rare case of post-colonoscopy polypectomy resulting in a pneumomediastinum and subcutaneous emphysema. Methods Used An 84 year old male with a history of colonoscopy with polypectomy the day prior was admitted Abstract P16 Figure 1 Air within the Left atrium with evidence of air fluid level due to a syncopal episode. The only complaint was a small amount of dark red blood per rectum. On examination vital signs were stable, the patient appeared pale with dry membrane mucosa, abdominal and pulmonary exam were benign, labs were concerning for a Hgb 6.9 g/dl. Chest X-ray depicted free air beneath the right hemidiaphragm, computed tomography demonstrated pneumoretroperitoneum, pneumomediastinum and subcutaneous emphysema.
P11 ADULT T CELL LYMPHOMA (ATL) MASQUERADING AS FACIAL NERVE PARALYSIS
P16 CARDIAC ARREST AS A CONSEQUENCE OF AIR EMBOLISM STATUS POST CT-GUIDED LUNG BIOPSY
P17 PNEUMOMEDIASTINUM A RARE COMPLICATION OF COLONOSCOPY POLYPECTOMY SUCCESSFULLY TREATED WITH CONSERVATIVE MANAGEMENT
Visceral angiogram failed to demonstrate any source of active bleeding. Due to the overall stable condition of the patient conservative management with prophylactic zosyn and transfusion of 2 units of packed red blood cells was initiated. Patient was discharged 5 days after admission with stable respiratory and hemodynamic signs. Summary of Results Diagnostic colonoscopies are relatively safe procedures with the most common complications being bleeding and perforations, with an incidence of less than .2%. Though perforations are rare they are associated with a high mortality and morbidity. Causes of perforation can be due to excessive insufflations, instrumental trauma and usually present with intra-abdominal free air but rarely with a pneumomediastinum. A pneumomediastinum is the presence of free air within the mediastinum and in our case was due to a micro-perforation from a colonic polypectomy. The colonic wall defect allowed free air into the retroperitoneum, which spread along the fascial planes and entered the mediastinum and subcutaneous tissues. The most sensitive test for pneumomediastinum is computed tomography and extra-pulmonary causes of pneumomediastinum can be successfully treated conservatively with rest and antibiotics. Conclusions Though complications from polypectomies are rare, they can be associated with a high morbidity and mortality but rarely associated with pneumomediastinum and in certain stable patients can be treated with conservative management. Purpose of Study Multicentric Castleman's disease (MCD) is a rare lymphoproliferative disorder characterized by peripheral lymphadenopathy (LAD), hepatosplenomegaly(HSM), and B symptoms. It is associated with HIVand HHV8 infection.
P18 MULTIPLE DIAGNOSIS OR CONTINUUM OF DISEASE: MULTICENTRIC CASTLEMAN'S DISEASE
We report a case of young woman presented with B symptoms, workup suggestive of lupus but lymph node biopsy (BX) was consistent with MCD. Association of SLE with MCD is rare. We report this case to increase awareness of this potential diagnostic and therapeutic dilemma. Methods Used Patient is a 27 yr old black woman presented with malaise, fevers, cough, weight loss, arthralgia, alopecia, numbness of extremities and Raynaud's phenomenon. Patient had skin tightness around the mouth, telangiectasia, digital ulcers, HSM, pitting edema, diffuse LAD and moderate pericardial effusion.
Laboratory results consistent with hemolytic anemia with Hb 5.6 g/dl, direct coombs positive, elevated reticulocyte count, LDH and low haptoglobin. Initial RF, ANA, and all infectious work up including HIV were normal. She was transfused cautiously, with inconclusive LN and bone marrow Bx. Patient left hospital against medical advice.
She presented two days later with altered mental status (AMS) and hypotension. CT head and Lumbar puncture were negative. Hypotension responded to fluids, but no response in AMS. Repeat ANA, AntiSSB, AntiSm, AntiRNP, and Antihistone antibodies were positive. Patient met diagnostic criteria for SLE and was subsequently treated for lupus cerebritis with pulse steroids, with moderate improvement in mental status. Repeat LNBX revealed reactive lymphadenitis with features of MCD, HHV8 negative. Patient was treated with IL-6 inhibitor Siltuximab, with significant improvement in mental status. Summary of Results MCD is a rare angiolymphoproliferative disorder of unclear etiology. Most cases occur in middle aged men and are associated with immunosuppression where as SLE is common in women of child bearing age. Reported cases of MCD in association with SLE are common in immunocompetent young women. Our patient is a young woman, HIV/HHV8 negative with good response to Siltuximab, favoring MCD. Conclusions It is unclear whether this finding of MCD and SLE represents an overlap or a pure association. However, this phenomenon needs further investigation.
P19 UNABLE TO BE PUBLISHED 10.1136/jim-2016-000080.59 Unable to be published. Purpose of Study The purpose of this study is to describe a link with allergic rhinitis, asthma and SLE..Allergy and autoimmunity results from this dysregulation. Allergens leads to i inflammation of mast cells via IgE-allergen and immune complexes linked with SLE. Type I allergy, Th2-driven disease based on IgE recognition of environmental allergens occurs in allergic rhinitis and asthma. Methods Used A described case report in a 49 year old Hispanic man with a history of SLE, diagnosed with Raynaud's, childhood asthma,, mental retardation, depression, pancreatitis and referred for a generalized rash for many years, unrelieved by albuterol steroid creams, sneezing, and nasal congestion. Summary of Results Type I and, Th2 allergy, environmental allergens occurs in allergic rhinitis and asthma. Autoimmunity and environmental stresses contribute to both allergic and autoimmune diseases. SLE is a conditione due to interactions between genes, environment, and abnormalities of the adaptive immunity. T cells, polyclonal B cell activation, hypergammaglobulinemia, autoantibodies and immune complexes. Asthma and autoimmune disease are associated with increased incidence of ANA's suggesting the disease may have an autoimmune basis.
Our case describes a 49 year old man with SLE, diagnosed with Raynaud's, childhood asthma,, mental retardation, depression, pancreatitis and referred for a generalized rash sneezing, and nasal congestion,. Physical exam revealed normal vitals, bald head, diffuse facial skin freckles erythematous nasal turbinates,dermatitis of the lower extremity, normal cardiac finding, no wheezing or Raynaud's,.+ abdominal tenderness, sIgE testing was performed for allergic rhinitis. Conclusions This interesting case illustrates a clear link with symptoms of allergic rhinitis, asthma and SLE. Abstract P20 Figure 1 Autoallergy in Atopic Dermatitis
